Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabian Freitag

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Opinion in Oncology|July 14, 2020
New targets and technologies for CAR-T cellsFabian Freitag, Marius Maucher, Zeno Riester, et al.
Journal of Visualized Experiments : Jove|May 11, 2026
Evaluating Multimodal Functionality of Chimeric Antigen Receptor T Cells at Single-Cell Resolution through Optofluidics AnalysisJulia Franz, Fabian Freitag, Patrick Ho, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 25, 2025
Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphomaZeno Riester, Marlena Surowka, Nicole Seifert, et al.
Cell Reports. Medicine|October 7, 2025
ROR2-specific CAR T cells are effective against hematologic and solid tumors and well tolerated in miceJustus Weber, Michael Rade, Josefine Michael, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Metabolization of microbial postbiotic pentanoate drives anti-cancer CAR T cellsSarah Staudt, Fabian Nikolka, Markus Perl, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Opinion in Oncology|July 14, 2020
New targets and technologies for CAR-T cellsFabian Freitag, Marius Maucher, Zeno Riester, et al.
Journal of Visualized Experiments : Jove|May 11, 2026
Evaluating Multimodal Functionality of Chimeric Antigen Receptor T Cells at Single-Cell Resolution through Optofluidics AnalysisJulia Franz, Fabian Freitag, Patrick Ho, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 25, 2025
Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphomaZeno Riester, Marlena Surowka, Nicole Seifert, et al.
Cell Reports. Medicine|October 7, 2025
ROR2-specific CAR T cells are effective against hematologic and solid tumors and well tolerated in miceJustus Weber, Michael Rade, Josefine Michael, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Metabolization of microbial postbiotic pentanoate drives anti-cancer CAR T cellsSarah Staudt, Fabian Nikolka, Markus Perl, et al.
Pageof 1